Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prolonged elevation of plasma HMGB1 is associated with cognitive impairment in intensive care unit survivors.

Literature DB >> 32103282

Prolonged elevation of plasma HMGB1 is associated with cognitive impairment in intensive care unit survivors.

Emily Brück^1,2, Julie Lasselin^3,4, Ulf Andersson⁵, Peter V Sackey¹, Peder S Olofsson^6,7.

Abstract

Entities: Disease Gene

Mesh：

Substances：
HMGB1 Protein

Year: 2020 PMID： 32103282 DOI： 10.1007/s00134-020-05941-7

Source DB: PubMed Journal: Intensive Care Med ISSN： 0342-4642 Impact factor: 17.440

× No keyword cloud information.

5 in total

1. Anti-High Mobility Group Box 1 Antibody Therapy May Prevent Cognitive Dysfunction After Traumatic Brain Injury.

Authors: Yu Okuma; Hidenori Wake; Kiyoshi Teshigawara; Yu Takahashi; Tomohito Hishikawa; Takao Yasuhara; Shuji Mori; Hideo K Takahashi; Isao Date; Masahiro Nishibori
Journal: World Neurosurg Date: 2018-11-02 Impact factor: 2.104

Review 2. Extracellular HMGB1 as a therapeutic target in inflammatory diseases.

Authors: Ulf Andersson; Huan Yang; Helena Harris
Journal: Expert Opin Ther Targets Date: 2018-02-15 Impact factor: 6.902

3. HMGB1 mediates cognitive impairment in sepsis survivors.

Authors: Sangeeta S Chavan; Patricio T Huerta; Sergio Robbiati; S I Valdes-Ferrer; Mahendar Ochani; Meghan Dancho; Maya Frankfurt; Bruce T Volpe; Kevin J Tracey; Betty Diamond
Journal: Mol Med Date: 2012-09-07 Impact factor: 6.354

4. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats.

Authors: Jiyong Zhang; Hideo K Takahashi; Keyue Liu; Hidenori Wake; Rui Liu; Tomoko Maruo; Isao Date; Tadashi Yoshino; Aiji Ohtsuka; Shuji Mori; Masahiro Nishibori
Journal: Stroke Date: 2011-04-07 Impact factor: 7.914

Review 5. Cognitive impairment after intensive care unit admission: a systematic review.

Authors: Annemiek E Wolters; Arjen J C Slooter; Arendina W van der Kooi; Diederik van Dijk
Journal: Intensive Care Med Date: 2013-01-18 Impact factor: 17.440

5 in total

3 in total

Prolonged elevation of plasma HMGB1 is associated with cognitive impairment in intensive care unit survivors.

1. Anti-High Mobility Group Box 1 Antibody Therapy May Prevent Cognitive Dysfunction After Traumatic Brain Injury.

Review 2. Extracellular HMGB1 as a therapeutic target in inflammatory diseases.

3. HMGB1 mediates cognitive impairment in sepsis survivors.

4. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats.

Review 5. Cognitive impairment after intensive care unit admission: a systematic review.

1. mTORC1-Dependent and GSDMD-Mediated Pyroptosis in Developmental Sevoflurane Neurotoxicity.

2. Vagus Nerve Stimulation Reduces Indomethacin-Induced Small Bowel Inflammation.

Review 3. Detection of immunogenic cell death and its relevance for cancer therapy.